Riastap vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQHT6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,091
Award facts
- Contract value 100% obligated
- $9,090.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,090.75 firm fixed-price delivery order for RIASTAP vials to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 11, 2025, with an ultimate completion date of January 5, 2026, represents a procurement of a specialized pharmaceutical product without set-aside designation. DMS Pharmaceutical Group Inc. competed for this award based on its established capabilities as a critical supplier within the federal pharmaceutical supply chain, with performance to be fulfilled at the company's Park Ridge location.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The parent IDC, awarded November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply a comprehensive range of pharmaceutical products to support Department of Defense military healthcare facilities worldwide. The delivery order structure enables efficient procurement of specialized medications and medical consumables to meet recurring federal pharmaceutical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FQHT6?
SPE2DR26FQHT6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FQHT6 worth?
The government has obligated $9,091 on SPE2DR26FQHT6.
Is contract SPE2DR26FQHT6 an order under another contract?
Yes. SPE2DR26FQHT6 is a delivery order under SPE2DR25D9759, an indefinite delivery contract.
Was contract SPE2DR26FQHT6 competed?
The extent of competition for SPE2DR26FQHT6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award